CTOs on the Move

Imagine Pharma

www.imaginepharma.com

 
Imagine Pharma is a drug discovery and development company that focuses on innovative approaches to therapeutic drugs for diabetes and cardiovascular disease. Our agile, creative and efficient approach to drug discovery is designed to find therapeutics that significantly improve on the efficacy and safety of existing treatments.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Pearl Health Clinic

Pearl Health Clinic provides unparalleled treatment to the community of Eastern Idaho and surrounding areas.

Senior Care Therapy

SCT helps New Jersey nursing homes improve care and reduce expenses by helping to better meet the phsycological needs of residents - at no cost to you

Boston Health Care for the Homeless Program

Since its founding in 1985, Boston Health Care for the Homeless Program has been guided by a simple mission - to provide and assure access to the highest quality health care for Bostons homeless men, women and children. http://www.bhchp.org

Aridis Pharmaceuticals

Aridis is a privately held biotechnology company located in San Jose, CA, USA which is focused on infectious diseases. Aridis has a strong portfolio of anti-infective product candidates, a human monoclonal antibody discovery platform technology, and best-in-class formulation technologies available for partnering. Our product portfolio comprises two monoclonal antibodies currently at Phase 2 clinical testing in patients, and two additional anti-infective drug candidates entering the IND development stage. Aridis’ suite of anti-infective monoclonal antibodies offers opportunities to profoundly impact current approaches to infection control. Aridis has raised over $20m in grant funding from leading institutions such as the National Institutes of Health, US Dept. of Defense, US Dept. of Health and Human Services’ BARDA, USAID, PATH/Gates Foundations, and Regional Centers of Excellence.

Design Therapeutics

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions.